InMed Pharmaceuticals Inc. (INM) reports FY EPS of ($3.25)

InMed Pharmaceuticals Inc. (NASDAQ: INM) reported FY EPS of ($3.25). Revenue for the FY came in at $4.14 million.

For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (INM) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Chagee Holdings (CHA) Tops Q2 EPS by 3c
• ULTA Beauty (ULTA) PT Lowered to $710 at UBS Amid Gross Margin Decline